UNIQUE BUSINESS IDENTIFIER / CRN
UBI 76187212
LiveLicensed Chinese Medicine Dealer · PW-2024-00088Licensed Drug Dealer · 68/2A/2025Former Names (1)

Baiyi Pharmaceutical Co., Limited

百益藥業有限公司

Official Verification: 2026-09-19
Inquiries: 0 Views
Jurisdiction: Hong Kong, ChinaJurisdiction: Hong Kong

Baiyi Pharmaceutical Co., Limited (百益藥業有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622). Its official Company Registration Number (CR No. / CRN) is 3365313, and Business Registration Number (BRN) is 76187212, classified as a Private company limited by shares. Incorporated on 2024-02-01, the entity has maintained continuous statutory operations for 2 years, currently holding an active legal status of Live. In terms of statutory licensing, the corporation is officially authorized and regulated in Hong Kong, holding Chinese Medicine Regulatory Office (CMRO) (Licence No. PW-2024-00088), Department of Health (DH Licensed Dealer) (Licence No. 68/2A/2025). The registered office is situated at ROOM ‍​​‌‌‌​​​​​‌‌​‌‌​​‌​​‌​​​​‌​​​​‌‌​​‌‌‌​‌​​​‌‌​​‌​​​‌‌​​​‌​​‌‌​‌‌​​​‌​‌‌‌​​​‌‌​‌‌‌​​‌‌​​‌‌​​‌‌‌​‌​​​‌‌​​‌​​​‌‌​‌‌​​​‌‌​​​​​​‌‌‌​​‌​​‌‌​​‌​​​‌‌​​​​​​‌‌‌​‌​​​‌‌​​‌​​​‌‌​​‌​​​‌‌​‌​​​​‌‌​​‌‌​​‌‌​‌​​​​‌‌​‌​‌​​‌‌​‌‌​18, 13/F, BLOCK B, METROPOLITAN FTY. & WH. BUILDING, 30-32 CHAI WAN KOK STREET, TSUEN WAN, HONG KONG.

I. Corporate Profile & Chinese Medicine Regulatory Office Licensed Trader Statutory Licensing Status (CMRO Licence: PW-2024-00088)

Official Chinese Name 百益藥業有限公司 Official English Name Baiyi Pharmaceutical Co., Limited
Business Reg No. (BRN) 76187212 Company Reg No. (CR / CRN) 3365313
Company Category Private company limited by shares Incorporation Date 2024-02-01
Current Legal Status Live Statutory Filing Cycle 2027-02-01(Completed for This Year)
Registered Office Address
ROOM ‍​​‌‌‌​​​​​‌‌​‌‌​​‌​​‌​​​​‌​​​​‌‌​​‌‌‌​‌​​​‌‌​​‌​​​‌‌​​​‌​​‌‌​‌‌​​​‌​‌‌‌​​​‌‌​‌‌‌​​‌‌​​‌‌​​‌‌‌​‌​​​‌‌​​‌​​​‌‌​‌‌​​​‌‌​​​​​​‌‌‌​​‌​​‌‌​​‌​​​‌‌​​​​​​‌‌‌​‌​​​‌‌​​‌​​​‌‌​​‌​​​‌‌​‌​​​​‌‌​​‌‌​​‌‌​‌​​​​‌‌​‌​‌​​‌‌​‌‌​18, 13/F, BLOCK B, METROPOLITAN FTY. & WH. BUILDING, 30-32 CHAI WAN KOK STREET, TSUEN WAN, HONG KONG
Significant Controllers (SCR) Pursuant to Part 12 Division 2A of Cap. 622, SCR registers are kept at the registered office. Penetration of ultimate beneficial owners (UBO) and offshore holding hierarchies available via comprehensive Due Diligence Report.
Name Evolution
(1 Former Name)
2024-02-01 Founding Incorp. Name
康國貿易有限公司Kangguo Trading Co., Limited
2025-03-10 Current Legal Name
百益藥業有限公司Baiyi Pharmaceutical Co., Limited

II. Licensed Chinese Medicine Trader Document Retrieval (Annual Return NAR1 / Articles / ND2A / CTC)

#Filing DateDocument No.Document NamePagesTariffAction
1 2026-2-2 23502368894
NAR1Annual Return (2026) (English)
2026-2-2·23502368894·11p·HK$ 28
11 HK$ 28
2 2026-2-2 22001965077
ND2ANotice of Change of Company Secretary and Director (English)
2026-2-2·22001965077·3p·HK$ 20
3 HK$ 20
3 2025-11-14 22001912130
ND2ANotice of Change of Company Secretary and Director (English)
2025-11-14·22001912130·4p·HK$ 20
4 HK$ 20
4 2025-11-14 22001912129
ND4Notice of Resignation of Company Secretary and Director (English)
2025-11-14·22001912129·2p·HK$ 20
2 HK$ 20
5 2025-3-10 40023711865
REG_REFCR Statutory Filing Document
2025-3-10·40023711865·1p·HK$ 20
1 HK$ 20
6 2025-3-10 23002463230
NNC2Notice of Change of Company Name pursuant to Direction (English)
2025-3-10·23002463230·1p·HK$ 20
1 HK$ 20
7 2025-3-4 24001773464
ND4Notice of Resignation of Company Secretary and Director (English)
2025-3-4·24001773464·2p·HK$ 20
2 HK$ 20
8 2025-3-4 24001773463
ND2ANotice of Change of Company Secretary and Director (English)
2025-3-4·24001773463·3p·HK$ 20
3 HK$ 20
9 2025-2-19 23102368696
ND2ANotice of Change of Company Secretary and Director (English)
2025-2-19·23102368696·3p·HK$ 20
3 HK$ 20
10 2025-2-19 22902937933
NAR1Annual Return (2025) (English)
2025-2-19·22902937933·9p·HK$ 28
9 HK$ 28

III. Commercial Due Diligence & Licensed Chinese Medicine Trader Responsible Person & Proprietary Medicine Compliance

Statutory Licences (32 Regulators) Licensed Entity
Chinese Medicine Regulatory Office (CMRO)
Active (Licensed)
Licence No. PW-2024-00088
Department of Health (DH Licensed Dealer)
Active (Licensed)
Licence No. 68/2A/2025
Court Litigation & Dockets No Public Dockets
Screen civil disputes, commercial claims, and criminal dockets across High Court, District Court, and Small Claims Tribunal. No public litigation records found.
Insolvency & Sanctions Screening Clean Record
Cross-check Official Receiver’s Office records for compulsory winding-up petitions, liquidator appointments, and creditor notices.
Office & Address Verification Address Resolved
ROOM ‍​​‌‌‌​​​​​‌‌​‌‌​​‌​​‌​​​​‌​​​​‌‌​​‌‌‌​‌​​​‌‌​​‌​​​‌‌​​​‌​​‌‌​‌‌​​​‌​‌‌‌​​​‌‌​‌‌‌​​‌‌​​‌‌​​‌‌‌​‌​​​‌‌​​‌​​​‌‌​‌‌​​​‌‌​​​​​​‌‌‌​​‌​​‌‌​​‌​​​‌‌​​​​​​‌‌‌​‌​​​‌‌​​‌​​​‌‌​​‌​​​‌‌​‌​​​​‌‌​​‌‌​​‌‌​‌​​​​‌‌​‌​‌​​‌‌​‌‌​18, 13/F, BLOCK B, METROPOLITAN FTY. & WH. BUILDING, 30-32 CHAI WAN KOK STREET, TSUEN WAN, HONG KONG
Hong Kong Corporate Due Diligence & Risk Screening Service

IV. Licensed Chinese Medicine Trader Compliance & Statutory Licensing FAQ

Baiyi Pharmaceutical Co., Limited is a legitimate Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622) of Hong Kong on 2024-02-01 (operating for 2 years). According to the official register of the Hong Kong Companies Registry (CR), the entity holds an active statutory status of [Live / In Operation] (Statutory records last verified: September 2026).

The statutory identifiers for this corporation issued by Hong Kong SAR authorities are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [76187212] (effective from 27 December 2023, this 8-digit number serves as the official cross-departmental primary identifier and tax ID); 2. Company Registration Number (CRN): [3365313] (historical archive number issued by Companies Registry). In international banking KYC, trade bills of lading, and cross-border contracts, these two numbers uniquely confirm entity legitimacy.

Under Hong Kong law, incorporated companies do not maintain a 'legal representative' position; the Board of Directors exercises supreme statutory management authority. Under the New Inspection Regime of the Companies Ordinance, public inspection protects directors' personal identification by displaying correspondence addresses and masked ID numbers. To retrieve the complete certified directorship history, shareholding structure (Form NAR1), Significant Controllers Register (SCR), and multi-tier UBO beneficial ownership penetration, apply through 86hc.com for an official due diligence dossier.

According to the official statutory records of the Companies Registry, Baiyi Pharmaceutical Co., Limited has officially recorded 1 legal name change(s): [Kangguo Trading Co., Limited (effective 2024-2-1)]. The current registered legal name was confirmed upon issuance of a Certificate of Change of Name by the Registrar of Companies. Screening former names is essential to uncover historical litigation and corporate credit track records.

Yes. 86hc.com comprehensively indexes the official filing registers of the Hong Kong Companies Registry, supporting verified retrieval of official statutory dossiers for this corporation. Pursuant to Section 107 of the Companies Ordinance (Cap. 622), private companies must deliver an Annual Return (Form NAR1) within 42 days of each incorporation anniversary. Available verified original dossiers include: latest Annual Return (Form NAR1 - detailing current share capital, registered office, directors, and shareholders), Incorporation Form (Form NNC1/NC1), Articles of Association, and Change of Company Secretary and Director notices (Form ND2A). Rapid document fulfillment within 15-30 minutes and Certified True Copies (CTC) signed by practicing Hong Kong CPAs are supported.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: Officially licensed by Hong Kong statutory authorities, currently holding: Chinese Medicine Regulatory Office (CMRO) (Licence No. PW-2024-00088); Department of Health (DH Licensed Dealer) (Licence No. 68/2A/2025); 2. Judicial Litigation & Winding-Up: screening across the Court of Final Appeal, High Court, District Court, and Official Receiver's Office (ORO) shows no active compulsory winding-up petitions on file.

V. Similar Trade Names & Industry Directory

Retrieve Filings